Annual Report 2003-2004 of Sun Pharmaceutical Industries Limited

It is a broadly described annual report of Sun Pharmaceutical Industries Limited in the year of 2003-2004. During the financial year, The Company’s Total Income Rs. 9598 million. Net Profit after Tax for the year Rs. 2594 million. Total income increased 9.84% over last year. Preference Share Rs. 9/-. Equity shares final Rs. 603. Book value per equity share (Rs. 5 paid up) Rs. 93/-. During the year under review, The Company’s Market share at 3.11% in March 2004 up from 2.99% in March 2003.

The Board of Directors is pleased to recommend the dividend of 6% p.a. (previous year 6% p.a.) on the paid up amount of preference shares and an interim equity dividend at the rate of 65% post bonus (equivalent to 130 % pre bonus-previous year 100% p.a.) for the year ended 31^st March 2004.

More Annual Report of Sun Pharmaceutical Industries Limited: